Soliton (SOLY) is developing a RAP (rapid acoustic pulse) technology for the removal of tattoos and for the treatment of cellulite. The majority of tattoo removal market is dominated by laser and operation procedures and Soliton is looking to capitalize off the cheaper and more efficient way of dealing with it.
The primary risk factor is the fact that they've been operating, in one form or another, since 2012 and have only now begun receiving proof-of-concept and other FDA authorizations to test their products, so in the grand scheme of things, they've had